We are live on
!
Find out more
CS
Candriam SCA Portfolio holdings
AUM
$19.3B
1-Year Est. Return
39.18%
This Fund
S&P 500
This Quarter
Est. Return
+9.06%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$14.6B
AUM Growth
+$2.6B
(+22%)
Cap. Flow
+$859M
Cap. Flow
% of AUM
5.88%
Top 10 Holdings %
Top 10 Hldgs %
21.92%
Holding
958
New
131
Increased
364
Reduced
334
Closed
74
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$135M |
| 2 |
Royal Bank of Canada
RY
|
+$120M |
| 3 |
Agilent Technologies
A
|
+$72.5M |
| 4 |
UnitedHealth
UNH
|
+$71.5M |
| 5 |
Regeneron Pharmaceuticals
REGN
|
+$64.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$90.3M |
| 2 |
Amgen
AMGN
|
+$88.7M |
| 3 |
Allstate
ALL
|
+$52.2M |
| 4 |
Union Pacific
UNP
|
+$47.1M |
| 5 |
Bio-Rad Laboratories Class A
BIO
|
+$44.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 33.42% |
| 2 | Technology | 23.2% |
| 3 | Consumer Discretionary | 9.14% |
| 4 | Financials | 8.63% |
| 5 | Communication Services | 7.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
351
Dominion Energy
D
$61.8B
| $6.55M | 0.04% |
57,300
-4,591
| -7% | -$354K |
|
352
General Motors
GM
$78.7B
| $6.54M | 0.04% |
110,515
-810
| -0.7% | -$47.6K |
|
353
Veeva Systems
VEEV
$31.6B
| $6.54M | 0.04% |
21,028
+5,402
| +35% | +$1.51M |
|
354
Ardelyx
ARDX
$1.25B
| $6.45M | 0.04% |
851,291
-520,926
| -38% | -$3.85M |
|
355
HCA Healthcare
HCA
$86.4B
| $6.44M | 0.04% |
31,158
-33,597
| -52% | -$6.85M |
|
|
XYZ
356
Block Inc
XYZ
$48.4B
| $6.44M | 0.04% |
26,404
+3,036
| +13% | +$704K |
|
357
Capital One
COF
$127B
| $6.37M | 0.04% |
41,178
+14,284
| +53% | +$2.15M |
|
358
Teladoc Health
TDOC
$1.61B
| $6.31M | 0.04% |
37,924
+10,890
| +40% | +$1.76M |
|
359
FTI Consulting
FCN
$4.88B
| $6.29M | 0.04% |
+46,066
| New | +$6.48M |
|
|
KRTX
360
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $6.24M | 0.04% |
+54,750
| New | +$6.4M |
|
361
Micron Technology
MU
$1.02T
| $6.23M | 0.04% |
73,320
-31,853
| -30% | -$2.69M |
|
|
USCR
362
DELISTED
U S Concrete, Inc.
USCR
| $6.16M | 0.04% |
+83,516
| New | +$5.4M |
|
|
CERN
363
DELISTED
Cerner Corp
CERN
| $6.16M | 0.04% |
78,810
-157,346
| -67% | -$12.1M |
|
364
Tractor Supply
TSCO
$16.7B
| $6.13M | 0.04% |
164,800
-43,910
| -21% | -$1.61M |
|
365
Repligen
RGEN
$7.39B
| $6.08M | 0.04% |
+30,470
| New | +$5.91M |
|
366
ARS Pharmaceuticals
SPRY
$572M
| $6.07M | 0.04% |
196,557
+196,544
| +1,511,877% | +$6.3M |
|
|
LDL
367
DELISTED
Lydall, Inc.
LDL
| $6M | 0.04% |
+99,198
| New | +$3.82M |
|
368
Halliburton
HAL
$26.8B
| $5.99M | 0.04% |
259,002
+143,877
| +125% | +$3.2M |
|
369
ConocoPhillips
COP
$141B
| $5.99M | 0.04% |
98,286
+13,432
| +16% | +$749K |
|
370
Copart
CPRT
$27.6B
| $5.96M | 0.04% |
180,968
+48,336
| +36% | +$1.5M |
|
371
T. Rowe Price
TROW
$25.5B
| $5.87M | 0.04% |
29,636
-39,917
| -57% | -$7.46M |
|
372
Planet Fitness
PLNT
$4.29B
| $5.82M | 0.04% |
77,320
-6,423
| -8% | -$511K |
|
373
Prudential Financial
PRU
$42.3B
| $5.78M | 0.04% |
56,388
-165,957
| -75% | -$17M |
|
374
Twilio
TWLO
$29.5B
| $5.76M | 0.04% |
14,623
+3,085
| +27% | +$1.07M |
|
375
Dropbox
DBX
$7.13B
| $5.59M | 0.04% |
184,507
+184,462
| +409,916% | +$5.04M |
|
Similar funds
PCM
A
MGP
LF
SOMRS
BPA
MIM
Candriam SCA's Q2 2021 Portfolio in Review
As of Q2 2021, Candriam SCA held 958 positions worth $14.6B, up 22% from $12B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Candriam SCA deployed $859M of net new capital in Q2 2021, opening 131 new positions and adding to 364 existing holdings. Its largest new stake was SailPoint Technologies Holdings, Inc. Common Stock: 738,233 shares worth $37.7M.
By sector, the portfolio is most concentrated in Healthcare at 33% of assets, down from 34% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Bristol-Myers Squibb, an estimated $90.3M trimmed.
- Candriam SCA's largest Q2 2021 buy was SailPoint Technologies Holdings, Inc. Common Stock: 738,233 shares worth $37.7M.
- Candriam SCA added most to Microsoft in Q2 2021, an estimated $135M increase.
- Candriam SCA's biggest Q2 2021 reduction was Bristol-Myers Squibb, cutting an estimated $90.3M.
- Candriam SCA fully exited Tenable Holdings in Q2 2021, selling an estimated $31.6M.
- Candriam SCA's ten largest holdings make up 22% of its $14.6B portfolio in Q2 2021.
- Candriam SCA opened 131 new positions and closed 74 in Q2 2021.
- Candriam SCA's portfolio value rose 22% quarter-over-quarter to $14.6B.
Based on Candriam SCA's 13F filing for Q2 2021, filed 20 Jul 2021.